Lipase test: what it measures, normal levels, and what a high lipase means

Lipase splits dietary fat into fatty acids and glycerol so the intestine can absorb them. The pancreas makes nearly all of it and releases it into the small intestine; small amounts also come from the stomach and the tongue, but in a healthy adult those contribute little to what circulates. As with amylase, a trickle of enzyme leaks into the blood continuously and the kidneys clear it, so the blood level reflects a steady state.

When the pancreas is inflamed, enzyme floods into the blood. Lipase starts rising within four to eight hours of the onset of pain, peaks at around 24 hours and stays elevated for eight to fourteen days, which is a longer and more forgiving window than amylase. Combined with its pancreatic specificity, that timing is why the American College of Gastroenterology's 2024 guideline prefers lipase over amylase when a single enzyme is measured for suspected acute pancreatitis.

The test reports units per liter (U/L). It measures how much enzyme is present, not how badly the pancreas is injured: a lipase of five times normal and one of thirty times normal can accompany attacks of identical severity, and the number is not used to grade or track the illness.

The primary use is the emergency evaluation of sudden, severe upper-abdominal pain that often radiates to the back, with nausea and vomiting. Acute pancreatitis is diagnosed when two of three criteria are met: that pain, lipase or amylase at least three times the upper limit of normal, and characteristic findings on imaging. That evaluation belongs in an emergency department the same day, not in an online order.

Away from the emergency room, lipase is used to follow a known episode back to normal, to investigate milder or intermittent upper-abdominal pain in people at risk (heavy alcohol use, gallstones, very high triglycerides, a prior attack, a family history of pancreatitis or pancreatic cancer), and to look for a pancreatic explanation when a routine panel shows something unexplained. It is included in pancreatic function panels for those reasons.

The question that brings many people to this page is GLP-1 medication. Semaglutide, tirzepatide, liraglutide and dulaglutide raise lipase and amylase modestly in a meaningful share of users, usually to less than three times the upper limit and without symptoms. Prescribing information and the American Diabetes Association do not recommend routinely monitoring the enzymes in people who feel well, because mild elevations are common and do not predict pancreatitis, but new persistent upper-abdominal pain on one of these drugs should prompt a lipase test and a call to the prescriber.

Lipase is available as a standalone blood test, paired with amylase, or inside a pancreatic function panel. It can be ordered by your doctor, or online through TestWell for a draw at a Quest or Labcorp patient service center, with a licensed physician reviewing the order and results delivered to your portal within a few business days. Pairing it with amylase costs little and gives the pattern that resolves most ambiguous results.

Most laboratories ask for an eight-hour fast before a lipase test, so schedule a morning draw with water only. Avoid alcohol for at least 24 hours. Medications that can raise lipase include opioid pain relievers, some diuretics, certain HIV medicines, valproate, and GLP-1 receptor agonists; tell the ordering physician about all of them, and about any recent abdominal procedure or imaging with contrast, so the result is read in context.

An unexpectedly high lipase in someone with no symptoms is repeated in a few weeks together with amylase and a kidney function check before anything else is done. A single mildly elevated value on a routine panel is very often a medication effect or a clearance effect that resolves or proves stable.

A typical adult reference range is about 13 to 60 U/L, with the exact figures set by the laboratory's method; your report shows the range for the lab that ran the test. Levels do not differ meaningfully between men and women and change little with age in adults, although older adults may sit slightly higher because kidney clearance declines.

Read the result in bands. Up to about three times the upper limit is a non-specific elevation: kidney disease, bowel inflammation or obstruction, gallbladder disease, celiac disease, diabetic ketoacidosis, medications and GLP-1 drugs all produce values here, and so does pancreatitis in its early or resolving phase. Three times the upper limit or more is the diagnostic threshold for acute pancreatitis when the pain fits; in the absence of pain it still warrants a look at the pancreas and gallbladder with imaging. How far above the threshold the number climbs carries no information about severity.

A normal lipase makes acute pancreatitis unlikely when the pain is fresh, because the enzyme rises within hours, but it does not exclude chronic pancreatitis, in which a scarred gland may produce little enzyme, or pancreatic cancer. Those conditions are investigated with imaging and, for digestive symptoms, a fecal elastase test.

Acute pancreatitis is the cause that matters, and gallstones and alcohol account for most cases, followed by very high triglycerides, medications, procedures such as ERCP, trauma and, less often, genetic and autoimmune causes. Beyond pancreatitis, the pancreatic causes include a pseudocyst, a duct obstruction from a stone or tumor and a flare of chronic pancreatitis.

Because lipase is cleared by the kidneys, reduced kidney function is one of the most common reasons for a mild, persistent elevation in someone with no abdominal symptoms; the level tracks creatinine rather than the pancreas. Inflammation or injury of the bowel (obstruction, ischemia, perforation, inflammatory bowel disease), gallbladder inflammation, celiac disease and diabetic ketoacidosis also raise lipase, as do the medications listed above and, modestly, the GLP-1 receptor agonists. A rare benign condition called macrolipasemia, analogous to macroamylasemia, produces a persistently high level with a healthy pancreas.

The pattern with amylase and the clinical picture separate these. A lipase of three times normal or more with the characteristic pain is pancreatitis until proven otherwise; a mild elevation with a raised creatinine is usually clearance; a mild elevation on a GLP-1 drug in someone who feels well is monitored, not treated; and an isolated persistent elevation with normal imaging and normal kidneys is followed rather than chased.

Lipase below the reference range is unusual and, when it means anything, points to a pancreas that has lost much of its enzyme-producing tissue: advanced chronic pancreatitis, cystic fibrosis, pancreatic cancer or previous pancreatic surgery. The digestive consequence is exocrine insufficiency, with oily or floating stools, bloating, weight loss and low levels of the fat-soluble vitamins A, D, E and K.

A low blood lipase is not itself the test for insufficiency. Fecal elastase, measured on a single stool sample, is; imaging of the pancreas usually follows. A low value in someone with no digestive symptoms and no risk factors is generally an incidental finding.

The two enzymes are ordered as a pair because each covers the other's weaknesses. Lipase is more specific to the pancreas, rises earlier and stays elevated longer, so it catches attacks that amylase has already missed and is the enzyme guidelines prefer. Amylase adds the salivary glands to the picture and, through a urine test, identifies macroamylasemia. Either enzyme at three times the upper limit satisfies the laboratory criterion in the revised Atlanta classification of acute pancreatitis.

Neither should be re-checked daily to judge how an attack is going: both fall on their own schedule regardless of the patient's course. Repeating them is useful only to confirm that a symptom-free elevation has settled.

A high lipase with severe abdominal pain, vomiting, fever or a fast heart rate is a same-day emergency evaluation for pancreatitis, whatever the exact number. Without symptoms, a mild elevation is repeated in a few weeks with amylase and creatinine. If it persists, an ultrasound looks for gallstones and a CT or MRI examines the pancreas; triglycerides, calcium, alcohol intake and the medication list are reviewed at the same time because those are the causes that can be changed. A persistent elevation with normal imaging and normal kidneys is usually followed at intervals rather than investigated further.

On a GLP-1 medicine, a symptom-free elevation under three times the upper limit is generally noted and the drug continued, with instructions to report abdominal pain; the prescriber makes that call. A low lipase with digestive symptoms leads to a fecal elastase test and pancreatic imaging. Rapidly worsening pain, a rigid abdomen, confusion or shortness of breath alongside a high lipase need emergency care.